Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells |
Bae, Sung Hun
(College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University)
Park, Ju Ho (College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University) Choi, Hyeon Gyeom (Department of Systems Biotechnology, Konkuk Institute of Technology (KIT), Konkuk University) Kim, Hyesook (Detroit R&D Inc) Kim, So Hee (College of Pharmacy and Research Institute of Pharmaceutical Science and Technology, Ajou University) |
1 | Aftab, B. T., Dobromilskaya, I., Liu, J. O. and Rudin, C. M. (2011) Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer. Cancer Res. 71, 6764-6772. DOI |
2 | Antonarakis, E. S., Heath, E. I., Smith, D. C., Rathkopf, D., Blackford, A. L., Danila, D. C., King, S., Frost, A., Ajiboye, A. S., Zhao, M., Mendonca, J., Kachhap, S. K., Rudek, M. A. and Carducci, M. A. (2013) Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. Oncologist 18, 163-173. DOI |
3 | Baroniya, S., Anwer, Z., Sharma, P. K., Dudhe, R. and Kumar, N. (2010) Recent advancement in imidazole as anticancer agents: a review. Der Pharmacia Sinica 1, 172-182. |
4 | Bockstaele, L., Coulonval, K., Kooken, H., Paternot, S. and Roger, P. P. (2006) Regulation of CDK4. Cell Div. 1, 25. DOI |
5 | Bray, F., Ren, J. S., Masuyer, E. and Ferlay, J. (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 132, 1133-1145. DOI |
6 | Cook, K. L., Shajahan, A. N., Warri, A., Jin, L., Hilakivi-Clarke. L. A. and Clarke, R. (2012) Glucose-regulated protein 78 controls crosstalk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Res. 72, 3337-3349. DOI |
7 | Furtado, C. M., Marcondes, M. C., Sola-Penna, M., de Souza, M. L. and Zancan, P. (2012) Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis. PLoS ONE 7, e30462. DOI |
8 | Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D. and Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. Available from: http://globocan.iarc.fr/. |
9 | Forgue-Lafitte, M. E., Coudray, A. M., Fagot, D. and Mester, J. (1999) Effects of ketoconazole on the proliferation and cell cycle of human cell lines. Cancer Res. 52, 827-6831. |
10 | Fujita, Y., Kimura, M., Sato, H., Takata, T., Ono, N. and Nishio, K. (2016) Characterization of the cytotoxic activity of [2]rotaxane (TRO-A0001), a novel supramolecular compound, in cancer cells. Arch. Pharm. Res. 39, 825-832. DOI |
11 | Furtado, C. M., Marcondes, M. C., Carvalho, R. S., Sola-Penna, M. and Zancan, P. (2015) Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole. Int. J. Biochem. Cell Biol. 62, 132-141. DOI |
12 | Liao, C. L., Lai, K. C., Huang, A. C., Yang, J. S., Lin, J. J., Wu, S. H., Gibson Wood, W., Lin, J. G. and Chung, J. G. (2012) Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways. Food Chem. Toxicol. 50, 1734-1740. DOI |
13 | Gong, Y., Chippada-Venkata, U. D. and Oh, W. K. (2014) Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel) 6, 1298-1327. DOI |
14 | Ho, Y. S., Tsai, P. W., Yu, C. F., Liu, H. L., Chen, R. J. and Lin, J. K. (1998) Ketoconazole-induced apoptosis through p53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines. Toxicol. Appl. Pharmacol. 153, 39-47. DOI |
15 | Hulkower, K. I. and Herber, R. L. (2011) Cell migration and invasion assays as tools for drug discovery. Pharmaceutics 3, 107-124. DOI |
16 | Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., Reya, T., Liu, J. O., Epstein, E. H., Stevens, D. A. and Beachy, P. A. (2010) Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 17, 388-399. DOI |
17 | Li, D. H., Hu, P., Xu, S. T., Fang, C. Y., Tang, S., Wang, X. Y., Sun, X. Y., Li, H., Xu, Y., Gu, X. K. and Xu, J. Y. (2017) Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects. Arch. Pharm. Res. 40, 796-806. DOI |
18 | Lim, S. J., Choi, H. G., Jeon, C. K. and Kim, S. H. (2015) Increased chemoresistance to paclitaxel in the MCF10AT series of human breast epithelial cancer cells. Oncol. Rep. 33, 2023-2030. DOI |
19 | Marcondes, M. C., Fernandes, A. C., Itabaiana, I., Jr., de Souza, R. O., Sola-Penna, M. and Zancan, P. (2015) Nanomicellar formulation of clotrimazole improves its antitumor action toward human breast cancer cells. PLoS ONE 10, e0130555. DOI |
20 | Mander, S., You, D. J., Park, S., Kim, D. H., Yong, H. J., Kim, D. S., Ahn, C., Kim, Y. H., Seong, J. Y. and Hwang, J. I. (2018) Nafamostat mesilate negatively regulates the metastasis of triple-negative breast cancer cells. Arch. Pharm. Res. 41, 229-242. DOI |
21 | Kadavakollu, S., Stailey, C., Kunapareddy, C. S. and White, S. (2014) Clotrimazole as a cancer drug: a short review. Med. Chem. 4, 722-724. |
22 | Shim, J. S. and Liu, J. O. (2014) Recent advances in drug repositioning for the discovery of new anticancer drugs. Int. J. Biol. Sci. 10, 654-663. DOI |
23 | Maurice, M., Pichard, L., Daujat, M., Fabre, I., Joyeux, H., Domergue, J. and Maurel, P. (1992) Effects of imidazole derivatives on cytochrome P-450 from human hepatocytes in primary culture. FASEB J. 6, 752-758. DOI |
24 | Ohnishi, T. (2005) The role of the p53 molecule in cancer therapies with radiation and/or hyperthermia. J. Cancer Res. Ther. 1, 147-150. DOI |
25 | Pantziarka, P., Sukhatme, V., Bouche, G., Meheus, L. and Sukhatme, V. P. (2015) Repurposing drugs in oncology (ReDO)-itraconazole as an anti-cancer agent. Ecancermedicalscience 9, 521. |
26 | Steeg, P. S. (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904. DOI |
27 | Tsubamoto, H., Ueda, T., Inoue, K., Sakata, K., Shibahara, H. and Sonoda, T. (2017) Repurposing itraconazole as an anticancer agent. Oncol. Lett. 14, 1240-1246. DOI |
28 | Taplin, M. E., Regan, M. M., Ko, Y. J., Bubley, G. J., Duggan, S. E., Werner, L., Beer, T. M., Ryan, C. W., Mathew, P., Tu, S. M., Denmeade, S. R., Oh, W. K., Sartor, O., Mantzoros, C. S., Rittmaster, R., Kantoff, P. W. and Balk, S. P. (2009) Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clin. Cancer Res. 15, 7099-7105. DOI |
29 | Tran, B. N., Nguyen, H. T., Kim, J. O., Yong, C. S. and Nguyen, C. N. (2017) Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. Arch. Pharm. Res. 40, 1420-1432. DOI |
30 | Tripathi, K. D. (2013) Essentials of Medical Pharmacology, 7th ed, p. 791. JP Medical Ltd, London. |
31 | Zhao, H. G., Zhou, S. L., Lin, Y. Y., Dai, H. F. and Huang, F. Y. (2018) Toxicarioside N induces apoptosis in human gastric cancer SGC-7901 cell by activating the p38MAPK pathway. Arch. Pharm. Res. 41, 71-78. DOI |
32 | Vasaitis, T. S., Bruno, R. D. and Njar, V. C. (2011) CYP17 inhibitors for prostate cancer therapy. J. Steroid Biochem. Mol. Biol. 125, 23-31. DOI |
33 | Yang, S. F., Chen, M. K., Hsieh, Y. S., Yang, J. S., Zavras, A. I., Hsieh, Y. H., Su, S. C., Kao, T. Y., Chen, P. N. and Chu, S. C. (2010) Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food Chem. Toxicol. 48, 1052-1058. DOI |
34 | Zhang, R., Pan, X., Huang, Z., Weber, G. F. and Zhang, G. (2011) Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS ONE 6, e23831. DOI |